CareLit Fachartikel

Patient Acceptance of Semi-Inpatient Radioligand Therapy: Insights from a Prospective Survey in Nuclear Medicine

Jonas Kaufmann, Carsten Kattinger, Stephanie Blümel, Christina Bartel, Mia Hami Glaß, Paul Martin Dahlke, Maximilian Thormann, Yasmin Ströhl, Anna Herden, Tristan Ruhwedel, Giulia Metzger, Markus Galler, Julian Manuel Michael Rogasch, Holger Amthauer, Michael… · Nuklearmedizin - NuclearMedicine · 2026 · Heft 10

Dokument
995541
CareLit-ID
Jahr
2026
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Nuklearmedizin - NuclearMedicine
Autor:innen
Jonas Kaufmann, Carsten Kattinger, Stephanie Blümel, Christina Bartel, Mia Hami Glaß, Paul Martin Dahlke, Maximilian Thormann, Yasmin Ströhl, Anna Herden, Tristan Ruhwedel, Giulia Metzger, Markus Galler, Julian Manuel Michael Rogasch, Holger Amthauer, Michael…
Ausgabe
Heft 10 / 2026
Seiten
–
Erschienen: 2026-10-26 00:00:00
ISSN
0029-5566
DOI
10.1055/a-2966-9616

Zusammenfassung

Abstract Aim Radioligand therapy with lutetium-177 is an effective treatment option for patients with metastatic castration-resistant prostate cancer and metastatic neuroendocrine tumors. In Germany, radiation protection laws require hospitalization with isolation, which may cause capacity problems. Internationally, models show the feasibility of non-inpatient radioligand therapy under strict safety measures. Patient acceptance is crucial for the implementation of flexible care models. This study aimed to assess patient preferences, concerns and requirements for non-inpatient radioligand therapy. Methods An a…

Schlagworte

radioligand therapy Lutetium-177-PSMA patient acceptance semi-inpatient treatment prostate cancer Germany Nuklearmedizin - NuclearMedicine